Thyrocare Technologies Limited

NSE THYROCARE.NS

Thyrocare Technologies Limited Debt to Equity Ratio for the year ending March 31, 2024: 0.08

Thyrocare Technologies Limited Debt to Equity Ratio is 0.08 for the year ending March 31, 2024, a 84.24% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Thyrocare Technologies Limited Debt to Equity Ratio for the year ending March 31, 2023 was 0.04, a 10.98% change year over year.
  • Thyrocare Technologies Limited Debt to Equity Ratio for the year ending March 31, 2022 was 0.04, a 97.84% change year over year.
  • Thyrocare Technologies Limited Debt to Equity Ratio for the year ending March 31, 2021 was 0.02, a -41.43% change year over year.
  • Thyrocare Technologies Limited Debt to Equity Ratio for the year ending March 31, 2020 was 0.03, a 490.51% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
NSE: THYROCARE.NS

Thyrocare Technologies Limited

CEO Mr. Rahul Franklin Guha
IPO Date May 10, 2016
Location India
Headquarters D/37-3, TTC Industrial Area
Employees 1,693
Sector Health Care
Industries
Description

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.

Similar companies

NH.NS

Narayana Hrudayalaya Limited

USD 14.93

1.77%

LALPATHLAB.NS

Dr. Lal PathLabs Limited

USD 32.39

-1.98%

SYNGENE.NS

Syngene International Limited

USD 9.56

0.73%

JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

USD 20.35

-1.23%

METROPOLIS.NS

Metropolis Healthcare Limited

USD 21.63

-0.42%

StockViz Staff

January 16, 2025

Any question? Send us an email